A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma

NCT04444141 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Due to difficuty of erollment and consideration of clinical guideline,The sponsor decided to stop study.

Conditions

Interventions

Sponsor

Akeso

Collaborators